China SXT Pharmaceuticals, Inc. Sustainability Profile
China SXT Pharmaceuticals, Inc., commonly referred to as SXT Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2005, the company has established itself as a leader in the development and production of traditional Chinese medicine and modern pharmaceutical products, catering to both domestic and international markets. SXT Pharmaceuticals focuses on innovative herbal formulations and high-quality over-the-counter medications, setting itself apart with a commitment to research and development. The company has achieved significant milestones, including expanding its operational reach across Asia and beyond, while maintaining a strong market position through its unique product offerings. With a dedication to enhancing health and wellness, SXT Pharmaceuticals continues to make strides in the evolving landscape of the pharmaceutical sector.
DitchCarbon Score
How does China SXT Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China SXT Pharmaceuticals, Inc.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China SXT Pharmaceuticals, Inc.'s reported carbon emissions
China SXT Pharmaceuticals, Inc., headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that China SXT Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments from China SXT Pharmaceuticals, it is challenging to assess their position relative to industry standards or peers.
How Carbon Intensive is China SXT Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is China SXT Pharmaceuticals, Inc.'s Location?
China SXT Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
China SXT Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
